Gum disease chemical clue: adropin levels may reveal hidden inflammation

NCT ID NCT07695857

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study measures levels of a substance called adropin in the gum fluid and blood of people with periodontitis (severe gum disease) and compares them to healthy gums. Researchers want to see if adropin changes after standard non-surgical gum treatment, and how it relates to a known inflammation marker, TNF-alfa. The goal is to better understand the body's response to gum disease and its treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nonsurgical periodontal therapy (scaling and root planing)
What this could lead to
If adropin levels change with treatment, it may point to a new marker for gum disease severity or healing.
What could go wrong
This is a small, early observational study. It only looks at chemical levels, not long-term health outcomes, and may not apply to smokers or people with other diseases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Giresun University

    Giresun, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.